Encompass Health Statistics Share Statistics Encompass Health has 100.8M
shares outstanding. The number of shares has increased by 0.17%
in one year.
Shares Outstanding 100.8M Shares Change (YoY) 0.17% Shares Change (QoQ) 0.09% Owned by Institutions (%) 94.65% Shares Floating 99.21M Failed to Deliver (FTD) Shares 31 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 988.91K, so 0.98% of the outstanding
shares have been sold short.
Short Interest 988.91K Short % of Shares Out 0.98% Short % of Float 1.1% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 20.25 and the forward
PE ratio is 20.31.
Encompass Health's PEG ratio is
0.72.
PE Ratio 20.25 Forward PE 20.31 PS Ratio 1.72 Forward PS 1.8 PB Ratio 4.46 P/FCF Ratio 25.61 PEG Ratio 0.72
Financial Ratio History Enterprise Valuation Encompass Health has an Enterprise Value (EV) of 11.85B.
EV / Sales 2.21 EV / EBITDA 9.99 EV / EBIT 11.82 EV / FCF 32.9
Financial Position The company has a current ratio of 1.05,
with a Debt / Equity ratio of 1.31.
Current Ratio 1.05 Quick Ratio 1.05 Debt / Equity 1.31 Debt / EBITDA 2.29 Debt / FCF 7.53 Interest Coverage 6.29
Financial Efficiency Return on Equity is 22.05% and Return on Invested Capital is 11.75%.
Return on Equity 22.05% Return on Assets 6.97% Return on Invested Capital 11.75% Revenue Per Employee $188.06K Profits Per Employee $15.95K Employee Count 28,572 Asset Turnover 0.82 Inventory Turnover n/a
Taxes Income Tax 150.2M Effective Tax Rate 20.04%
Stock Price Statistics The stock price has increased by 35.18% in the
last 52 weeks. The beta is 0.74, so Encompass Health's
price volatility has been higher than the market average.
Beta 0.74 52-Week Price Change 35.18% 50-Day Moving Average 116.42 200-Day Moving Average 105.27 Relative Strength Index (RSI) 61.86 Average Volume (20 Days) 860,543
Income Statement In the last 12 months, Encompass Health had revenue of 5.37B
and earned 455.7M
in profits. Earnings per share was 4.53.
Revenue 5.37B Gross Profit 2.47B Operating Income 864.5M Net Income 455.7M EBITDA 1.19B EBIT 887M Earnings Per Share (EPS) 4.53
Full Income Statement Balance Sheet The company has 85.4M in cash and 2.71B in
debt, giving a net cash position of -2.63B.
Cash & Cash Equivalents 85.4M Total Debt 2.71B Net Cash -2.63B Retained Earnings 796.7M Total Assets 6.79B Working Capital 53M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 1B
and capital expenditures -642.5M, giving a free cash flow of 360.3M.
Operating Cash Flow 1B Capital Expenditures -642.5M Free Cash Flow 360.3M FCF Per Share 3.61
Full Cash Flow Statement Margins Gross margin is 46.01%, with operating and profit margins of 16.09% and 8.48%.
Gross Margin 46.01% Operating Margin 16.09% Pretax Margin 13.95% Profit Margin 8.48% EBITDA Margin 22.08% EBIT Margin 16.09% FCF Margin 6.71%
Dividends & Yields EHC pays an annual dividend of $0.87,
which amounts to a dividend yield of 0.6%.
Dividend Per Share $0.87 Dividend Yield 0.6% Dividend Growth (YoY) 13.33% Payout Ratio 16.96% Earnings Yield 4.94% FCF Yield 3.91%
Dividend Details Analyst Forecast The average price target for EHC is $135,
which is 15% higher than the current price. The consensus rating is "Buy".
Price Target $135 Price Target Difference 15% Analyst Consensus Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $43.31 Lynch Upside -63.12% Graham Number 46.08 Graham Upside -60.76%
Stock Splits The last stock split was on Jul 1, 2022. It was a
forward
split with a ratio of 1257:1000.
Last Split Date Jul 1, 2022 Split Type forward Split Ratio 1257:1000
Scores Altman Z-Score 3.23 Piotroski F-Score 7
